Subsequent Events	9 Months Ended
Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	NOTE 12. SUBSEQUENT EVENTS On July 1, 2015 Regen Biopharma, Inc. issued 412,242 of its shares of common stock as consideration for services rendered by a nonemployee.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

No definition available.

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration